Current Firm
Health Technology Holding (HTH)
Investments
1+ companies
Focus
AI, Fintech
Michelle Gaiotto is a healthcare venture capital investor at HTH who combines statistical training with over $1 billion in cross-asset investment management experience, giving her an unusually quantitative perspective compared to many early-stage healthcare VCs. She serves as both CEO of HTH and actively leads financings while taking board positions at technical medical companies, positioning her as both a firm leader and hands-on deal champion who invests globally from her base in Italy.
Michelle Gaiotto is a Managing Principal, Health Technology Holding (HTH) at Health Technology Holding (HTH).
Michelle's investment focus spans AI, Fintech, Enterprise, Consumer, Biotech, Cybersecurity, Climate, DevTools, Robotics, SaaS, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Marco Gullà. These investments span AI and Fintech.
Michelle Gaiotto is a Managing Principal, Health Technology Holding (HTH) at Health Technology Holding (HTH). Their investment focus includes AI, Fintech, Enterprise.
Michelle Gaiotto focuses on investments in AI, Fintech, Enterprise, Consumer, Biotech, Cybersecurity, Climate, DevTools, Robotics, SaaS through Health Technology Holding (HTH). These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Michelle Gaiotto's notable portfolio investments include Marco Gullà. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Michelle Gaiotto is currently at Health Technology Holding (HTH), serving as Managing Principal, Health Technology Holding (HTH).